Clik here to view.
CATIE News – Geriatric syndromes found to be common in some HIV-positive people
Thanks to the many benefits of potent combination anti-HIV therapy (commonly called ART or HAART) more HIV-positive people in Canada and similar countries are living longer. The power of ART is so...
View ArticleClik here to view.
CATIE News – A community-based program successfully engages participants in...
Despite the availability of a cure, many people living with hepatitis C are not being tested, diagnosed, linked to care and treated for hepatitis C. A study of the American hepatitis C continuum of...
View ArticleClik here to view.
CATIE Treatment Update 208
In this issue: HEPATITIS C VIRUS Grazoprevir + elbasvir and other emerging drugs Enter ledipasvir Sirius—ledipasvir + sofosbuvir in cases of severe liver injury Using ledipasvir + sofosbuvir when...
View ArticleClik here to view.
CATIE News – French study hints at marijuana’s potential for reducing...
Thanks to the widespread availability of potent combination anti-HIV therapy (commonly called ART or HAART), many HIV-positive people are living longer and researchers increasingly expect that some of...
View ArticleClik here to view.
CATIE News – Predictors of HIV-related peripheral neuropathy in the modern era
HIV infection can cause many problems, including some that affect the nerves. The nervous system that permeates the vast majority of the body outside of the brain is called the peripheral nervous...
View ArticleClik here to view.
CATIE HepCinfo Update 6.6
New warning issued for serious heart problems when Harvoni or sofosbuvir is taken with amiodarone The U.S. Food and Drug Administration (FDA) is warning that serious slowing of the heart rate...
View ArticleClik here to view.
CATIE HepCinfo Update 6.7
New and Noteworthy In this issue: Harvoni and sofosbuvir added to formularies in Alberta, Nova Scotia and Saskatchewan Sexual transmission of Hep C linked to anal sex, drug use and lower CD4 count...
View ArticleClik here to view.
CATIE News – Implementing a screening program for domestic abuse
Thanks to the availability of potent combination anti-HIV therapy (commonly called ART or HAART), many people with HIV are living longer in high-income countries such as Canada. As a result,...
View ArticlePHAC – Public Release of two population-specific prevention resources
The Programs and Partnerships Division at the Public Health Agency of Canada is pleased to announce the release of two new resources entitled “Chlamydia among young women: A resource for...
View ArticleClik here to view.
CATIE HepCinfo Update 6.8
In this issue Two new FDA warnings issued for simeprevir FDA grants new breakthrough therapy designation for grazoprevir and elbasvir Good adherence to Harvoni shown in two clinical trials Two new FDA...
View ArticleClik here to view.
CATIE – A Practical Guide to a Healthy Body for People Living with HIV
HIV and the medications used to control it can have many long-term effects. CATIE has developed a comprehensive guide to long-term health for people living with HIV. It is designed to help you...
View ArticleClik here to view.
CATIE’s HepCinfo Update 6.10
New and Noteworthy Grazoprevir and elbasvir effective in people who have never been treated before 90% cure rate in people with advanced liver injury with grazoprevir and elbasvir High levels of...
View ArticleQuestions and Answers: Prevention of sexually transmitted and blood borne...
The Centre for Communicable Diseases and Infection Control of the Public Health Agency of Canada is pleased to announce the release of a new resource entitled Questions & Answers: Prevention of...
View ArticleClik here to view.
CATIE News – Study confirms starting HIV treatment early prevents illness and...
A large, well-designed clinical trial called START has confirmed that by initiating anti-HIV therapy early—when their CD4+ cell counts are still relatively high—HIV-positive people can significantly...
View ArticleClik here to view.
CATIE News – Tesamorelin (Egrifta) comes to Canada – what you need to know
Last week, Theratechnologies Inc. began marketing a new medicine called tesamorelin (Egrifta)—licensed for the treatment of excess belly fat in some HIV-positive people. Tesamorelin causes the body to...
View ArticleClik here to view.
CATIE’s Summer 2015 Positive Side newsletter
Hot off the press: the Summer 2015 edition of The Positive Side, CATIE’s health and wellness magazine for people living with HIV. In this issue: From the Front Lines: Well, well, well… HIV...
View ArticleClik here to view.
CATIE News – Study finds large savings from investment in community-based HIV...
Chronic illness can have a huge impact on the economies of cities, regions and countries. Researchers in the U.S. have estimated that the lifetime cost of care for HIV can range from about $250,000 to...
View ArticleClik here to view.
CATIE News – Leading Canadian researcher calls for inclusion of co-infected...
Hepatitis C virus (HCV) infects the liver. Chronic infection with HCV causes inflammation in this vital organ and slowly degrades it as healthy tissue is replaced with scar tissue. This ongoing injury...
View ArticleClik here to view.
CATIE/ACT Resource – Hep C and Sex for Gay, Bi and Queer Men
In recent years, groups of gay, bi and queer men – especially HIV-positive men but also HIV-negative men – have become Hep C positive through sex. Find out more in Hep C and Sex for Gay, Bi and Queer...
View ArticleClik here to view.
CATIE News – Study finds large savings from investment in community-based HIV...
Chronic illness can have a huge impact on the economies of cities, regions and countries. Researchers in the U.S. have estimated that the lifetime cost of care for HIV can range from about $250,000 to...
View Article